During a live event, Matthew Galsky, MD, discussed adjuvant nivolumab in muscle-invasive bladder cancer and the benefit in ...

UroGen Pharma's potential remains strong despite market volatility, with promising FDA prospects for UGN-102 & a $5B ...

New bladder cancer treatment rolled out by NHS - Hundreds will benefit after the first targeted treatment for the most common ...

The drug, recommended by NICE, works by blocking certain proteins to slow down or stop the growth of cancer cells ...